News from biopharmx corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 15, 2020, 16:05 ET BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX" or the "Company"), a specialty pharmaceutical company focused on developing innovative...

May 13, 2020, 16:05 ET BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that all proposals related to its proposed merger with Timber...

May 08, 2020, 09:00 ET BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber...

Apr 27, 2020, 16:05 ET BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that the date of its special stockholders' meeting to consider and vote on...

Mar 25, 2020, 16:15 ET BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology...

Jan 28, 2020, 16:30 ET BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement

ioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company...

Dec 10, 2019, 16:05 ET BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Sep 20, 2019, 16:05 ET BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology...

Sep 09, 2019, 08:15 ET BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Jul 16, 2019, 16:15 ET BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Jun 25, 2019, 07:30 ET BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Jun 11, 2019, 16:10 ET BioPharmX Reports Fiscal First Quarter 2020 Financial Results

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

May 22, 2019, 08:10 ET BioPharmX Announces Last Patient Visit in Phase 2b Trial of BPX-04 for Papulopustular Rosacea

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products,...

Apr 26, 2019, 07:30 ET BioPharmX Completes 1-for-25 Reverse Stock Split

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology...

Apr 15, 2019, 16:15 ET BioPharmX Announces Reverse Stock Split

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology...

Mar 21, 2019, 08:55 ET BioPharmX Announces $3.9 Million Offering

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Mar 18, 2019, 06:45 ET BioPharmX to Participate in the 31st Annual ROTH Conference and the Oppenheimer 29th Annual Healthcare Conference

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Mar 14, 2019, 16:05 ET BioPharmX Reports Fourth Quarter and Full Year 2019 Financial Results

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Mar 04, 2019, 06:00 ET BioPharmX Completes Enrollment in Phase 2b Trial of BPX-04 for Patients with Papulopustular Rosacea

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Feb 27, 2019, 16:15 ET BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology...

Feb 04, 2019, 07:00 ET BioPharmX Strengthens Board of Directors with Appointment of Industry Veteran Dr. R. Todd Plott

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Dec 20, 2018, 16:30 ET BioPharmX Receives Notice of Noncompliance from NYSE American

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products,...

Dec 06, 2018, 16:10 ET BioPharmX Reports Third Quarter 2019 Financial Results

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today...

Nov 16, 2018, 06:00 ET BioPharmX Announces NYSE American Acceptance of Plan To Regain Listing Compliance

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company developing products for the dermatology market,...

Oct 11, 2018, 16:30 ET BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced that...